ATC Group: L04AD01 Ciclosporin

Position of L04AD01 in the ATC hierarchy

Level	Code	Title
1	L	Antineoplastic and immunomodulating agents
2	L04	Immunosuppressants
3	L04A	Immunosuppressants
4	L04AD	Calcineurin inhibitors
5	L04AD01	Ciclosporin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	0.25 g
PAREN	Parenteral	0.25 g

Active ingredients in L04AD01

Active Ingredient
Ciclosporin
Ciclosporin (also known as ciclosporin A) is a cyclic polypeptide immunomodulator with immunosuppressant properties. It has been shown to prolong survival of allogeneic transplants in animals and significantly improved graft survival in all types of solid organ transplantation in man. Ciclosporin has also been shown to have an anti-inflammatory effect.

Related product monographs

Document	Type	Information Source
DEXIMUNE Capsule, soft	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
NEORAL Oral solution	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
RESTASIS Emulsion	MPI, US: SPL/PLR	FDA, National Drug Code (US)
SANDIMMUN Concentrate for solution for infusion	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
SANDIMMUNE Capsule, Oral solution, Solution for injection	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicines in this ATC group

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.